Selective inhibition of regulatory immediate early (IE) genes of herpes simplex virus type 1 (HSV-1) should inhibit virus growth. Treatment of HSV-1-infected cells with the oligo(nucleoside methylphosphonate) d(TpCCTCCTG) (deoxynucleoside methylphosphonate residues in italic), which is complementary to the acceptor splice junction of HSV-1 IE pre-mRNA 4 and 5, before (1-24 hr) or at the time of infection caused a dose-dependent inhibition in virus replication. Virus titers were decreased 50% and 90% in cells treated with 25 ILM and 75 ,uM oligomer, respectively; at 300 tsM, a 99% reduction in virus production was observed. Viral DNA synthesis was reduced 70-75% and there was a 90% reduction in synthesis of viral proteins, including other LE species and viral functional (130-kDa major DNA-binding) and structural (glycoprotein gB) proteins. In the same concentration range, d(TpCCTC-CTG) caused a minimal reduction (0-30%) in protein synthesis and growth rates (<40%) of uninfected cells. The data suggest that oligo(nucleoside methylphosphonate)s may be effective in antiviral chemotherapy.
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Numerous nucleoside or nucleotide analogues have been screened for antiviral activity (1) . Their mode of action exploits differences in the specificity of viral versus host enzymes, thus affecting differentially the rate of viral as compared to host-cell nucleic acid synthesis. However, with rare exceptions, most of them are not effective in experimentally infected animals (2) .
An alternative approach to antiviral chemotherapy is the use of sequence-specific oligonucleotides or their analogues to selectively inhibit viral gene expression at the level of mRNA processing or translation. For this purpose we have developed sequence-specific nonionic nucleic acid analogues that contain a 3'-5' methylphosphonate group in place of the negatively charged phosphodiester group normally found in oligonucleotides (3) . These analogues are resistant to nuclease hydrolysis and penetrate mammalian cells in culture (4) . An oligo(deoxyribonucleoside methylphosphonate) complementary to the Shine-Dalgarno sequence of 16S ribosomal RNA inhibits protein synthesis in Escherichia coli, but not in mammalian cells (5) . Oligomers complementary to the initiation codon regions ofrabbit globin mRNA inhibit translation in a cell-free system and in rabbit reticulocytes (6) , while oligomers complementary to the initiation codon regions of vesicular stomatitis virus mRNAs inhibit viral but not cellular protein synthesis in infected mouse L cells (7) .
To explore the possibility that control of gene expression by methylphosphonates could be an effective antiviral modality, we synthesized an oligo(nucleoside methylphosphonate) [d(TpCCTCCTG) ; deoxynucleoside methylphosphonate residues in italic] that is complementary to the acceptor splice junction of herpes simplex virus type 1 (HSV-1) immediate early (IE) mRNAs 4 and 5 (8) . The rationale for this choice is based on previous findings indicating that (i) HSV proteins form at least three kinetic groups [IE(a); early, E(p); and late, L(y)] whose synthesis is coordinately regulated and sequentially ordered in a cascade fashion (9), (ii) IE genes play a regulatory role in virus replication (10, 11) , and (iii) RNA splicing may be involved in the control of gene expression (12, 13) . The effect of this oligo(nucleoside methylphosphonate) on HSV infectivity and on viral protein and DNA syntheses is described.
MATERIALS AND METHODS
Cells and Virus. Vero (African green monkey kidney) and human foreskin fibroblast cells (M. A. Bioproducts, Walkersville, MD) were grown in Eagle's minimal essential medium (MEM) with 25 mM Hepes buffer and 10% fetal bovine serum. The isolation and properties of HSV-1(F) and HSV-2-(G) have been described (14) .
Synthesis of d(TpCCTCCTG). IE mRNAs 4 and 5 each have a single splice site (Fig. 1) . Their common 5' termini lie within the short repeat segments of the genome, as do the 5' and 3' splice junction sites (8, 15) . d(TpCCTCCTG) is a sequence complementary to the previously described (8) sequence of the 3' acceptor splice junction in HSV-1. It was synthesized by solid-phase techniques on a polystyrene support and purified as described (16) . The oligomer, characterized as described by Murakami et Fig. 1 . Vero cells were exposed to various concentrations (0-300 p1M) of d(TpCCTCCTG) before (1-24 hr) , during (0 hr), or after (1 hr) infection with HSV-1 (3 pfu per cell), and virus titers were determined 24 hr later. Addition of d(TpC-CTCCTG) at the time of infection ( Fig. 2A) , or at 1-24 hr before infection (Fig. 2B) dose-dependent inhibition in the growth of HSV-2 (Fig. 2B) .
However, at concentrations of 25-100 A.M, its effect was less (by a factor of 1.5-2) than that observed for HSV-1, so that 50% inhibition in virus growth was observed in cultures exposed to 50 MM oligomer, as compared to 25 MM for HSV-1. At 300 MM, the oligomer inhibited the replication of both viruses equally well.
The inhibitory effect is sequence-specific, as evidenced by the failure of the oligomer to inhibit virus growth when modified by the inversion of the two central residues (C and T). Thus, at the same concentrations (10-75 AM) at which d(TpCCTCCTG) caused a 15-90o reduction in virus titers, d(TpCCCTCTG) did not inhibit virus infectivity (Fig. 2C) . Virus growth was also not inhibited by exposure to the unrelated hexamer d(TpTTTTT) at 10-100 mMM ( Fig. 2A) . AM).
They were incubated at 370C for 24 or 48 hr, at which times the cells from replicate wells were trypsinized and counted. At 24 hr after seeding, the total numbers of cells in cultures grown in the presence of 150 or 300 MM d(TpCCTCCTG) were similar to those observed in untreated cultures. At these high concentrations, growth rates were somewhat decreased by 48 hr after seeding (by factors of 1.3 and 1.6 for 300 and 150 ,M, respectively). However, there was no apparent decrease in the growth rates of cells exposed to lower (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) ,M) concentrations of d(TpCCTCCTG) (Fig. 3) (24) , the rate of amino acid incorporation into acid-insoluble material in HSV-1-infected cells increased at 4 hpi, reached maximal levels at 6-7 hpi (presumably reflecting the synthesis of viral proteins), and declined thereafter. On the other hand, the rate of amino acid incorporation into acid-insoluble material from cells infected in the presence of d(TpCCTCCTG) remained relatively stable (Fig. 4A) . Protein synthesis was reduced only 10-30% in mock-infected cells treated with 250 ,M oligomer ( (26) . The 3H in the nucleic acid from untreated infected cells localized in one band with a density of 1.725 g/cm3, consistent with that of viral DNA (26, 27) . There was virtually no radioactivity in the low-density fraction (1.70 g/cm3) consistent with host-cell DNA (Fig. 6A) . On the other hand, the 3H from a similarly centrifuged extract of d(TpCCTCCTG)-treated infected cells (Fig. 6B ) localized in two peaks with respective densities of viral and host-cell DNA. The level of radioactivity in the viral DNA peak was lower by a factor of 3.5-4 than that in the untreated cells, while there was a 6-fold increase in the amount of 3H in the cellular DNA peak.
DISCUSSION
Oligodeoxyribonucleotides (28) (29) (30) and oligo(deoxyribonucleoside methylphosphonates) (6, 7) can be used to control the expression of mRNA in vitro and in living cells. In this report, we describe the results of our studies with an eight-residue oligomer [d(TpCCTCCTG)] that is complementary to the acceptor splice junction of HSV-1 IE mRNAs 4 and 5 (Fig. 1) . Considerations leading to its selection include previous findings indicating that (i) HSV IE genes (10) , particularly that encoding for ICP22 (11) , play a regulatory role in virus growth and (ii) RNA splicing may be involved in the control of gene expression (12, 13) . The salient feature of the data is the finding that d(TpCCTCCTG) inhibits virus growth, while in the same concentration range (10-75 ,uM) it has little, if any, deleterious effect on host-cell macromolecular metabolism and growth rate.
HSV-1 replication is inhibited by d(TpCCTCCTG) in a dose-dependent fashion; 50% and 90% reductions, respectively, in virus titers are observed in cultures exposed to 25 ,uM and 75 ,uM. The inhibitory effect is almost immediate, as evidenced by the reduced level of inhibition in cultures treated at 1 hpi, and it appears to be sequence-specific. Thus, within the same concentration range (10-75 ,uM (23) and it inhibits the growth of HSV-2 almost as well as that of HSV-1 (Fig. 2) . A limited computer search has shown that the oligomer is also complementary to a 7-base sequence in the coding region of the mRNA for the L protein of vesicular stomatitis virus and to nucleotides 72-80 in the coding region of rabbit f3-globin mRNA. Consistent with these homologies, d(TpCCTCCTG) (150 ,uM) inhibits (85%) the synthesis of vesicular stomatitis virus in infected mouse L cells, as well as inhibiting the translation ofP-globin mRNA in a cell-free rabbit reticulocyte translation system (6) .
The concentration-dependence of the observed inhibitory effects is consistent with the nature of the physical binding interaction between the oligomer and HSV mRNA. Thus, the relative magnitude of the inhibitory effect increases more rapidly in the low (0-75 AM) than in the higher (75-300 ,AM) concentration range. It is apparent from these considerations that effective inhibition could be achieved at very low oligomer concentrations if the oligomer were irreversibly bound to the mRNA by crosslinking or by using the oligomer to cleave the mRNA. 
